News & Analysis

Latest content

Lenovo sues Asus amid surge of US patent litigation triggered by Chinese companies

It is only the third time the laptop maker has been involved in a patent infringement action in the US as a plaintiff

17 November 2023

US policymakers wading through stakeholder feedback on patents and technology standards

Public comments by the implementer and SEP holder camps show the ideological dividing lines that the USPTO, NIST, and International Trade Association need to navigate

16 November 2023

AI can super-charge private practice work – but experts warn that there are still considerable risks

Nine thought leaders stress that, while AI can transform how practitioners’ work, it cannot – and must not – replace them

16 November 2023

Regeneron asserts swathe of patents in latest Eylea biosimilar clash

Lawsuit is latest in a torrent of new BPCIA lawsuits to emerge over the past year

16 November 2023

Indian court opens up option for global FRAND rate setting in Nokia-Oppo dispute

Finnish SEP holder agrees to drop UK litigation to enable Delhi judge to proceed but Chinese implementer will not drop its home ground suit, IAM understands

16 November 2023

The EU should listen to its Nordic champions, not ignore them

When companies with the innovation and tech leadership credentials of Ericsson, Nokia and Novo Nordisk raise major concerns about Commission proposals, their arguments deserve serious consideration. But it’s not happening. No wonder Europe is losing the global competition race

15 November 2023

Samsung Display faces off with China’s BOE in ITC trade secrets spat

A recent complaint alleging OLED technology theft is evidence of the International Trade Commission’s growing importance as a trade secret litigation venue

15 November 2023

Micron targeted by Chinese semiconductor firm in US litigation

Yangtze Memory Technologies asserts that the US chipmaker infringes eight patents with its 3D NAND flash memory chips

15 November 2023

Bristol-Myers fighting intense battle to keep Eliquis generics off European markets

What you need to know about one of 2023's most important patent wars

14 November 2023

Chinese patent office hands down key ruling on pharma patent requirements

Two recent invalidation decisions shed light on how China’s patent re-examination board considers the disclosure of experimental data when considering priority

14 November 2023

Unlock unlimited access to all IAM content